SpeechPathology.com Phone: 800-242-5183


Epic Special Education Staffing - April 2023

Vanderbilt SLP Journal Club: Seizure Disorders and the Effects of Antiepileptic Medications on Cognitive-Communicative Functions

Vanderbilt SLP Journal Club: Seizure Disorders and the Effects of Antiepileptic Medications on Cognitive-Communicative Functions
Rima Abou-Khalil, PhD, CCC-SLP
September 26, 2016
Share:

This text-based course is a transcript of the webinar, Vanderbilt SLP Journal Club: Seizure Disorders and the Effects of Antiepileptic Medications on Cognitive-Communicative Functions, presented by Rima Abou-Khalil, PhD, CCC-SLP.

Learning Outcomes

  • After this course, participants will be able to describe the difference between seizures and epilepsy.
  • After this course, participants will be able to describe the complexity of seizure classification and treatment.
  • After this course, participants will be able to list 2-3 cognitive and linguistic effects of antiepilepsy drug (AED) treatments.

Introduction

Thank you for this opportunity to share some research on this very interesting topic. Today’s course will discuss the following:

  • Definition and classification of seizures
  • Definition and treatment of epilepsy
  • Epilepsy and cognition
  • Antiepileptic drugs (AEDs) and their effects on cognition
  • Topiramate (TPM) as an example of an AED with negative cognitive effects
  • Levetiracetam (LEV) as an example of an AED with possible positive effects on cognition

Why Should SLPs Care About this Topic?

We tend to work with neurogenic populations. Any kind of neurological damage increases a patient’s risk for seizures. Currently, the standard is that a person with TBI in the acute setting is immediately given Topiramate (a.k.a., Keppra) or Levetiracetam which is one of the medications that will be discussed later.  Keppra is used with acute TBI patients to help with prevention of seizures. A recent study found that about 4% of people with cortical strokes would develop seizures eventually. Many stroke patients, particularly if they're cortical stroke patients, are also given antiepileptic drugs.  Even with antiepileptic drugs used in the initial stages, some patient are going to develop epilepsy or seizures. They will remain on antiepileptic medication for a while. They come to us in inpatient and outpatient settings on these medications. Therefore, it's important for us to understand what they are going through.

Seizure Definition

Seizures are defined as transient signs or symptoms due to abnormal excessive or synchronous neural activity in the brain. This definition was generated by the International League Against Epilepsy (2014). The most important words are transient because a seizure has a finite beginning and a finite end and synchronous which means that it doesn't have to manifest as a clinical sign or symptom. It just has to be abnormal activity in the brain.

Seizure Classification

Clinically, seizures can have many different presentations. They are pretty challenging to classify so we're going to look at seizure classification at a simple level.

Partial

Seizures are classified as being focal (aka, partial). Focal seizures are those that begin within one hemisphere. They are considered to be simple if consciousness is not affected and complex if consciousness is affected. If the seizure begins in one hemisphere and consciousness is preserved, it's called a simple focal or simple partial seizure. If it begins in one hemisphere and consciousness is altered, then it's considered to be a focal complex seizure.


rima abou khalil

Rima Abou-Khalil, PhD, CCC-SLP

Rima Abou-Khalil received her Ph.D. from Vanderbilt University in 2003.  She is currently a faculty member at Vanderbilt University with clinical and research interests in acquired neurogenic disorders. 



Related Courses

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP
Video
Course: #9473Level: Intermediate1 Hour
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video
Course: #9732Level: Intermediate1 Hour
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.

Best Practice for Assessment and Treatment of Bilingual Aphasia
Presented by Maria Muñoz, PhD, CCC-SLP
Video
Course: #9759Level: Intermediate1.5 Hours
This course focuses on best practice in the assessment and treatment of bilingual aphasia by speech-language pathologists. Recommended practices are contrasted against common mistakes made by clinicians working with bilingual patients with aphasia. Implementation of best practices are modeled through case studies.

Social Isolation and COVID-19 Cognitive Decline: From Zero to Hero!
Presented by Amber B. Heape, ClinScD, CCC-SLP, FNAP, CMD, CMDCP
Video
Course: #9514Level: Intermediate1 Hour
Social distancing and isolation associated with the COVID-10 pandemic have begun to take a toll on patients in residential settings, but SLPs can help mitigate the long-term consequences. This course discusses the risk factors for and effects of isolation, as well as potential strategies to prevent or reverse pandemic-related cognitive decline.

Brain Health Basics: Strategies for SLPs to Support Healthy Aging for Adult Patients
Presented by Megan L. Malone, MA, CCC-SLP, Jennifer Loehr, MA, CCC-SLP
Video
Course: #9785Level: Introductory1 Hour
This Back to Basics course focuses on the preventative aspect of improving brain health with adult patients, with emphasis on elements that SLPs can target during instruction or counseling aspects of patient treatment and caregiver support. Additional information is provided on advocacy for these services and community outreach to organizations working with older adults.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.